TheCardiovascular

Articles & courses

Articles
🟠 QT Drugs: Drugs causing QT prolongation, torsade de pointes (TdP) and long QT syndrome (LQTS)

…or risk of torsade de pointes in PubMed. GnRH Antagonist Cancer (prostate) Synthetic decapeptide antagonist to gonadotropin releasing hormone (GnRH). <a href="http://www.ncbi…

Media

No matches.

Tests

Management of Heart Failure — A 65-year-old male is evaluated in the cardiology clinic for new-onset exertiona…

Tools

Drugs
Glucagon
ICD-10-CMShow all 70
Z17.42 — Hormone receptor nega…
Z17.420 — Hormone receptor neg…
Z17.421 — Hormone receptor neg…
Z17.411 — Hormone receptor pos…
Z17.41 — Hormone receptor posi…
Z17.410 — Hormone receptor pos…
Z17 — Estrogen, and other horm…
Z19 — Hormone sensitivity mali…
E34.2 — Ectopic hormone secret…
Z19.1 — Hormone sensitive mali…
KVÅShow all 11
3E013VJ — Introduction of Other Hormone into Subcutaneous Tissue, Percutaneous Approach
3E030VJ — Introduction of Other Hormone into Peripheral Vein, Open Approach
3E033VJ — Introduction of Other Hormone into Peripheral Vein, Percutaneous Approach
3E040VJ — Introduction of Other Hormone into Central Vein, Open Approach
3E043VJ — Introduction of Other Hormone into Central Vein, Percutaneous Approach
3E050VJ — Introduction of Other Hormone into Peripheral Artery, Open Approach
3E053VJ — Introduction of Other Hormone into Peripheral Artery, Percutaneous Approach
3E060VJ — Introduction of Other Hormone into Central Artery, Open Approach
3E063VJ — Introduction of Other Hormone into Central Artery, Percutaneous Approach
3E0P3VZ — Introduction of Hormone into Female Reproductive, Percutaneous Approach